SF
SVNT

Sarofim Fayez’s SAVIENT PHARMACEUTICALS INC SVNT Stock Holding History

Sarofim Fayez’s Portfolio SVNT Stock Details SVNT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2013
Q3 		$9K Buy
+13,860
New +$8.87K ﹤0.01% 233

Other funds holding SVNT

PAI
Palo Alto Investors Palo Alto, California $724M AUM 96.91% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
BCM
Bridgeway Capital Management Houston, Texas $5.69B AUM 60.64% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Sarofim Fayez's SVNT Position: Q3 2013 in Review

Sarofim Fayez opened a new position in SAVIENT PHARMACEUTICALS INC (SVNT) in Q3 2013: 13,860 shares worth $9K. The stake represents ﹤0.01% of the portfolio and ranks #233 among its holdings.

41 funds tracked by Wall St. Rank hold SVNT as of Q3 2013.

  • Sarofim Fayez held 13,860 shares of SAVIENT PHARMACEUTICALS INC worth $9K as of Q3 2013.
  • SAVIENT PHARMACEUTICALS INC was a new Sarofim Fayez position in Q3 2013.
  • SAVIENT PHARMACEUTICALS INC made up ﹤0.01% of Sarofim Fayez's portfolio in Q3 2013, its #233 holding.
  • 41 funds tracked by Wall St. Rank held SAVIENT PHARMACEUTICALS INC as of Q3 2013.

Based on Sarofim Fayez's 13F filing for Q3 2013, filed 14 Nov 2013.